MKI67 and central nervous system cancer: In TN-gliomas, TRATE predicted a high Ki67 (> 10%) expression with AUC = 0.84, and a cutoff of TRATE > 142 mM−1s−1 corresponded to sensitivity and specificity of 89% and 80% (Fig. 3c).